Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis
Clinical trial NCT03109236 · UNKNOWN
Trial details
- NCT number
- NCT03109236
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2022-12-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.